21-07-2025
Biocom California and Los Angeles County Economic Development Corporation Renew Memorandum of Understanding to Advance the Greater Los Angeles Life Science Ecosystem
LOS ANGELES & SAN DIEGO & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jul 21, 2025--
Biocom California, the association representing the California life science industry, and the Los Angeles County Economic Development Corporation (LAEDC), a leader in inclusive economic growth, today announced the renewal of a Memorandum of Understanding (MOU) aimed at strengthening the life science ecosystem in the Greater Los Angeles region.
'Greater Los Angeles is home to a thriving life science cluster, powered by world-class research institutions and a diverse, innovation-driven economy,' said Dan Gober, Executive Director, Los Angeles of Biocom California. 'This renewed partnership with LAEDC enables us to double down on the commitment we made when we first opened our Greater LA office in 2015 to address the unique needs of the LA life science community, connect it with complementary regional hubs across Southern California, and ensure that groundbreaking discoveries made here stay and scale here.'
Under the MOU, Biocom California and LAEDC will collaborate on strategic programs and initiatives to support growth and innovation in Los Angeles County's bioscience sector. Key objectives include aligning resources and networks to:
Los Angeles County is a critical player in the global bioeconomy, bolstered by internationally renowned institutions such as UCLA, USC, Cedars-Sinai Medical Center, Caltech and City of Hope. The region is home to more than 3,966 life science establishments, providing close to 200,000 jobs and generating over $60 billion in economic output. In 2024 alone, the region secured $1.51 billion in federal funding from the NIH and NSF, underscoring its prominence as a center of scientific advancement.
'LAEDC's partnership with Biocom California reflects our shared vision for inclusive and sustainable economic growth driven by innovation,' said Stephen Cheung, president and CEO of LAEDC. 'The life sciences are essential to that vision: delivering transformative health outcomes, creating quality jobs, and strengthening our position in global markets. Together, we will continue to support and elevate this high-impact industry throughout Los Angeles County.'
The MOU also outlines collaboration on signature events, joint policy and workforce initiatives, and the implementation of the LA County Bioscience Strategic Plan. Both organizations will engage public and private stakeholders, leveraging their unique assets to accelerate the life sciences sector's impact on local communities and the broader economy.
About Biocom California
Biocom California is the leader and advocate for California's life science sector. We work on behalf of our members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.
For more information on Biocom California, please visit our website at Connect with us on LinkedIn, Facebook and X.
View source version on
CONTACT: Biocom California Media Contact:
Carolyn Hawley
Inizio Evoke Comms
(619) 849-5382
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES GENETICS OTHER SCIENCE SCIENCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Biocom California
Copyright Business Wire 2025.
PUB: 07/21/2025 02:18 PM/DISC: 07/21/2025 02:18 PM
